What’s the STORY

What’s the STORY (Serum Testing of Representative Youngsters) Sero-epidemiological survey of England

Type: Observational (sero-epidemiology study)

Site and lead:

  • Royal Manchester Children’s Hospital: Dr Stephen Hughes

Patient group: Children


Sponsor: University of Oxford (Oxford Vaccine Group)

More about What’s the STORY

Initially designed to assess serological protection against vaccine preventable diseases such as diphtheria and group C meningococcus in 0 to 24-year-olds, following the COVID-19 outbreak the study has been adapted to evaluate the prevalence of antibodies against novel coronavirus SARS-CoV-2 in healthy children and adolescents.

Blood samples will be collected from 3,500 healthy 0 to 24-year-olds, accompanied by questionnaires on health and demographic data.

Recruitment is via invitation letter only and is sent out centrally from the study sponsor to a pre-selected cohort of patients within our area. Only families who receive this letter are eligible to take part.